1a ) plus fluorouracil/leucovorin (FOLFOX4) as palliative chemotherapy in HCC patients from Asia found that this regimen showed a trend toward improved overall survival, along with increased progression-free survival, although the primary end point was not met 6 .
← all excerpts
β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.
1
—
—